Quantitative Systematic Strategies’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-55,047
| Closed | -$560K | – | 479 |
|
|
2021
Q1 | $560K | Buy |
55,047
+29,849
| +118% | +$304K | 0.09% | 352 |
|
|
2020
Q4 | $188K | Sell |
25,198
-41,502
| -62% | -$310K | 0.03% | 564 |
|
|
2020
Q3 | $229K | Sell |
66,700
-8,551
| -11% | -$29.4K | 0.04% | 494 |
|
|
2020
Q2 | $359K | Buy |
75,251
+30,537
| +68% | +$146K | 0.07% | 380 |
|
|
2020
Q1 | $89K | Sell |
44,714
-56,090
| -56% | -$112K | 0.07% | 229 |
|
|
2019
Q4 | $348K | Buy |
100,804
+57,608
| +133% | +$199K | 0.05% | 414 |
|
|
2019
Q3 | $124K | Sell |
43,196
-394
| -0.9% | -$1.13K | 0.03% | 432 |
|
|
2019
Q2 | $165K | Buy |
43,590
+32,618
| +297% | +$123K | 0.03% | 424 |
|
|
2019
Q1 | $89K | Sell |
10,972
-21,843
| -67% | -$177K | 0.02% | 355 |
|
|
2018
Q4 | $265K | Buy |
32,815
+608
| +2% | +$4.91K | 0.06% | 449 |
|
|
2018
Q3 | $246K | Buy |
+32,207
| New | +$246K | 0.05% | 466 |
|
|
2017
Q2 | – | Sell |
-13,631
| Closed | -$115K | – | 441 |
|
|
2017
Q1 | $115K | Sell |
13,631
-141
| -1% | -$1.19K | 0.03% | 343 |
|
|
2016
Q4 | $88K | Buy |
+13,772
| New | +$88K | 0.04% | 286 |
|
|
2016
Q3 | – | Sell |
-63,918
| Closed | -$186K | – | 384 |
|
|
2016
Q2 | $186K | Buy |
+63,918
| New | +$186K | 0.09% | 289 |
|
|
2015
Q3 | – | Sell |
-41,609
| Closed | -$600K | – | 371 |
|
|
2015
Q2 | $600K | Buy |
+41,609
| New | +$600K | 0.13% | 267 |
|